Tempest Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $108.2M | $43.9M |
| FY2017 | $599.0K | $-130.7M | $17.6M |
| FY2018 | $383.0K | $71.0M | $73.3M |
| FY2019 | $168.0K | $-50.4M | $62.5M |
| FY2020 | $61.0K | $-68.8M | $18.8M |
| FY2021 | $15.1M | $36.1M | $51.8M |
| FY2022 | $10.4M | $18.1M | $31.2M |
| FY2023 | $6.3M | $26.8M | $39.2M |
| FY2024 | $0 | $19.1M | $30.3M |
| FY2025 | — | $6.7M | $7.7M |